James Garner, Kazia Therapeutics CEO

Lit­tle biotech de­vel­op­ing Genen­tech castoff drug hits hur­dle in glioblas­toma plat­form tri­al

When the Glob­al Coali­tion for Adap­tive Re­search brought the PI3K in­hibitor pax­al­is­ib in­to its plat­form tri­al for glioblas­toma in ear­ly 2021, the drug’s de­vel­op­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.